Biomaterials and tissue engineering strategies for posterior lamellar eyelid reconstruction: Replacement or regeneration?

Authors:
Yan Y; Ji Q; Fu R; Liu C; Yang J and 3 more

Journal:
Bioeng Transl Med

Publication Year: 2023

DOI:
10.1002/btm2.10497

PMCID:
PMC10354782

PMID:
37476060

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Bioeng Transl Med

Abbreviation: Bioeng Transl Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Engineering, Biomedical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
4D-CT deformable image registration using unsupervised recursive cascaded full-resolution residual …
Xu L; Jiang P; Tsui T and 4 more (2023) - Transparency Score: 3/6
Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflamm…
Deng C; Liu Q; Zhao H and 9 more (2023) - Transparency Score: 3/6
Adipose-derived stem cells enriched with therapeutic mRNA TGF-β3 and IL-10 synergistically promote …
Wang W; Chen L; Zhang Y and 5 more (2023) - Transparency Score: 4/6
Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic du…
Zhang H; Chen J; Hu X and 2 more (2023) - Transparency Score: 3/6
A drug-selectable acoustic reporter gene system for human cell ultrasound imaging.
Howells AR; Welch PJ; Kim J and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest."

Evidence found in paper:

"This research was supported by grants from the National Natural Science Foundation of China (81871571 to Ru‐Lin Huang), the Shanghai Pujiang Program (2019PJD023 to Ru‐Lin Huang), and the Shanghai Municipal Key Clinical Specialty (shslczdzk00901 to Ru‐Lin Huang)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025